True Wealth Design’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16
Closed -$91 2784
2025
Q3
$91 Hold
16
﹤0.01% 2465
2025
Q2
$61 Sell
16
-16
-50% -$50 ﹤0.01% 2346
2025
Q1
$85 Buy
+32
New +$104 ﹤0.01% 2254

True Wealth Design's SCPH Position: Q4 2025 in Review

True Wealth Design sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 16 shares — an estimated $91 sold.

True Wealth Design first reported a position in SCPH in Q1 2025 and held it in 3 quarters. The position peaked at $91 in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • True Wealth Design reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • True Wealth Design sold 16 scPharmaceuticals shares in Q4 2025, an estimated $91.
  • True Wealth Design first reported a position in scPharmaceuticals in Q1 2025 and held it in 3 quarters.
  • True Wealth Design's scPharmaceuticals position peaked at $91 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on True Wealth Design's 13F filing for Q4 2025, filed 8 Jan 2026.